Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
South African income tax number: 9432434182 ('Mediclinic', the 'Company', or the 'Group')
5 August 2022
NOTIFICATION: TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES & PERSONS CLOSELY ASSOCIATED WITH THEM
This notification sets out the details of awards over ordinary shares in Mediclinic ('Shares') granted to directors and other persons discharging managerial responsibilities ('PDMRs') on 5 August 2022 under the Company's short-term incentive scheme ('STI') and long-term incentive plan ('LTIP'), in accordance with the Remuneration Policy and share plan rules approved by shareholders at the annual general meeting of the Company held on 28 July 2022.
Name | Director/ | Number of | Number of Shares |
PDMR | Shares | awarded under | |
awarded | the LTIP | ||
under the STI | |||
Dr Carel Aron van der Merwe | Director | 74 718 | 237 716 |
Petrus Jurgens Myburgh | Director | 47 488 | 148 319 |
David John Hadley | PDMR | n/a | 58 369 |
Gert Cornelis Hattingh | PDMR | n/a | 28 716 |
Dr Dirk Cornelius le Roux | PDMR | n/a | 22 450 |
Dr Daniel Liedtke | PDMR | n/a | 52 074 |
Magnus Oetiker | PDMR | n/a | 51 945 |
Koert Hendrik Stefanus Pretorius | PDMR | n/a | 30 055 |
Dr René Toua | PDMR | n/a | 23 594 |
Dr Tyson Bruno Welzel | PDMR | n/a | 40 608 |
Greg van Wyk | PDMR | n/a | 27 270 |
The above awards were granted for nil consideration and are based on the closing price of a Share on 4 August 2022, which equates to £4.98 per Share.
1. Details of PDMR / person closely associated with them
a) | Name | Dr Carel Aron van der Merwe |
2. | Reason for the notification | ||
a) | Position / status | Group Chief Executive Officer - Mediclinic International plc | |
b) | Initial notification / | Initial Notification | |
amendment | |||
3. | Details of the issuer, emission allowance market participant, auction platform, | ||
auctioneer or auction monitor | |||
a) | Name | Mediclinic International plc | |
b) | LEI | 2138002S5BSBIZTD5I60 | |
4.1 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) | ||
each type of transaction; (iii) each date; and (iv) each place where transactions have | |||
been conducted | |||
a) | Description of the | Ordinary Shares | |
financial instrument | |||
Identification Code | GB00B8HX8Z88 | ||
b) | Nature of the | Award over ordinary shares in Mediclinic International plc granted at | |
transaction | nil cost under the Company's Short-Term Incentive scheme | ||
c) | Price(s) and | Price(s) | Volume(s) |
volume(s) | £nil | 74 718 | |
d) | Aggregated | ||
information | |||
Aggregated volume | 74 718 | ||
Price | £nil | ||
e) | Date of the | 5 August 2022 | |
transaction | |||
f) | Place of the | Outside a trading venue | |
transaction | |||
4.2 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) | ||
each type of transaction; (iii) each date; and (iv) each place where transactions have | |||
been conducted | |||
a) | Description of the | Ordinary Shares | |
financial instrument | |||
Identification Code | GB00B8HX8Z88 | ||
b) | Nature of the | Award over ordinary shares in Mediclinic International plc granted at | |
transaction | nil cost under the Company's Long-Term Incentive Plan | ||
c) | Price(s) and | Price(s) | Volume(s) |
volume(s) | £nil | 237 716 | |
d) | Aggregated | ||
information | |||
Aggregated volume | 237 716 | ||
Price | £nil | ||
e) | Date of the | 5 August 2022 | |||||
transaction | |||||||
f) | Place of the | Outside a trading venue | |||||
transaction | |||||||
1. | Details of PDMR / person closely associated with them | ||||||
a) | Name | Petrus Jurgens Myburgh | |||||
2. | Reason for the notification | ||||||
a) | Position / status | Group Chief Financial Officer - Mediclinic International plc | |||||
b) | Initial notification / | Initial Notification | |||||
amendment | |||||||
3. | Details of the issuer, emission allowance market participant, auction platform, | ||||||
auctioneer or auction monitor | |||||||
a) | Name | Mediclinic International plc | |||||
b) | LEI | 2138002S5BSBIZTD5I60 | |||||
4.1 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) | ||||||
each type of transaction; (iii) each date; and (iv) each place where transactions have | |||||||
been conducted | |||||||
a) | Description of the | Ordinary Shares | |||||
financial instrument | |||||||
Identification Code | GB00B8HX8Z88 | ||||||
b) | Nature of the | Award over ordinary shares in Mediclinic International plc granted at | |||||
transaction | nil cost under the Company's Short-Term Incentive scheme | ||||||
c) | Price(s) and | Price(s) | Volume(s) | ||||
volume(s) | £nil | 47 488 | |||||
d) | Aggregated | ||||||
information | |||||||
Aggregated volume | 47 488 | ||||||
Price | £nil | ||||||
e) | Date of the | 5 August 2022 | |||||
transaction | |||||||
f) | Place of the | Outside a trading venue | |||||
transaction | |||||||
4.2 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) | ||||||
each type of transaction; (iii) each date; and (iv) each place where transactions have | |||||||
been conducted | |||||||
a) | Description of the | Ordinary Shares | |||||
financial instrument | |||||||
Identification Code | GB00B8HX8Z88 | ||||||
b) | Nature of the | Award over ordinary shares in Mediclinic International plc granted at | |||||
transaction | nil cost under the Company's Long-Term Incentive Plan | ||||||
c) | Price(s) and | Price(s) | Volume(s) |
volume(s) | £nil | 148 319 | |
d) | Aggregated | ||
information | |||
Aggregated volume | 148 319 | ||
Price | £nil | ||
e) | Date of the | 5 August 2022 | |
transaction | |||
f) | Place of the | Outside a trading venue | |
transaction | |||
1. | Details of PDMR / person closely associated with them | ||
a) | Name | David John Hadley | |
2. | Reason for the notification | ||
a) | Position / status | Chief Executive Officer - Mediclinic Middle East | |
b) | Initial notification / | Initial Notification | |
amendment | |||
3. | Details of the issuer, emission allowance market participant, auction platform, | ||
auctioneer or auction monitor | |||
a) | Name | Mediclinic International plc | |
b) | LEI | 2138002S5BSBIZTD5I60 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) | ||
each type of transaction; (iii) each date; and (iv) each place where transactions have | |||
been conducted | |||
a) | Description of the | Ordinary Shares | |
financial instrument | |||
Identification Code | GB00B8HX8Z88 | ||
b) | Nature of the | Award over ordinary shares in Mediclinic International plc granted at | |
transaction | nil cost under the Company's Long-Term Incentive Plan | ||
c) | Price(s) and | Price(s) | Volume(s) |
volume(s) | £nil | 58 369 | |
d) | Aggregated | ||
information | |||
Aggregated volume | 58 369 | ||
Price | £nil | ||
e) | Date of the | 5 August 2022 | |
transaction | |||
f) | Place of the | Outside a trading venue | |
transaction |
1. | Details of PDMR / person closely associated with them | ||
a) | Name | Gert Cornelis Hattingh | |
2. | Reason for the notification | ||
a) | Position / status | Group Chief Governance Officer - Mediclinic International plc | |
b) | Initial notification / | Initial Notification | |
amendment | |||
3. | Details of the issuer, emission allowance market participant, auction platform, | ||
auctioneer or auction monitor | |||
a) | Name | Mediclinic International plc | |
b) | LEI | 2138002S5BSBIZTD5I60 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) | ||
each type of transaction; (iii) each date; and (iv) each place where transactions have | |||
been conducted | |||
a) | Description of the | Ordinary Shares | |
financial instrument | |||
Identification Code | GB00B8HX8Z88 | ||
b) | Nature of the | Award over ordinary shares in Mediclinic International plc granted at | |
transaction | nil cost under the Company's Long-Term Incentive Plan | ||
c) | Price(s) and | Price(s) | Volume(s) |
volume(s) | £nil | 28 716 | |
d) | Aggregated | ||
information | |||
Aggregated volume | 28 716 | ||
Price | £nil | ||
e) | Date of the | 5 August 2022 | |
transaction | |||
f) | Place of the | Outside a trading venue | |
transaction | |||
1. | Details of PDMR / person closely associated with them | ||
a) | Name | Dr Dirk Cornelius le Roux | |
2. | Reason for the notification | ||
a) | Position / status | Group Chief Information Officer - Mediclinic International plc | |
b) | Initial notification / | Initial Notification | |
amendment |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Mediclinic International plc published this content on 05 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 August 2022 14:55:06 UTC.